NCT00690066Phase 2Completed

PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)

Study sponsor: Mesoblast, Inc.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2010-12-12Actual
Enrollment · participants63Actual
Source updated2026-03-11Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.